Key result
Combined AT1 and alpha-1 blockade reverses hypertension in NO-blocked rats despite persistent renal vascular resistance.
Why the study?
Does combined AT1 and alpha 1-adrenoceptor blockade reduce blood pressure in rats with chronic NO blockade-induced hypertension?
Does combined AT1 and alpha 1-adrenoceptor blockade reduce blood pressure in rats with chronic NO blockade-induced hypertension?
Hypertension induced by chronic NO blockade in rats is largely mediated by the combined activities of alpha 1-adrenoceptor and AT1 stimulation.
Should not guide clinical use of combined blockade; extends mechanistic insight in NO-deficient rat hypertension.
Nitric oxide (NO) is a tonically produced vasodilator that maintains blood pressure (BP) in the normal animal. In these studies, we produced chronic NO blockade by oral administration of the NO synthesis inhibitor nitro-L-arginine methyl ester (L-NAME), which produced sustained hypertension and increased renal vascular resistance (RVR) in conscious rats. Acute blockade of the angiotensin II type 1 (AT1) receptor with losartan had little effect on BP and RVR in either chronically NO-blocked or normal conscious rats. Acute blockade of the alpha 1-adrenoceptor with prazosin produced moderate similar falls in BP in both chronically NO-blocked and normal rats. The combination of AT1 and alpha 1-adrenoceptor blockade was profoundly antihypertensive and was particularly effective in lowering BP in chronically NO-blocked rats where the hypertension was obliterated. In contrast, the increased RVR persisted in chronically NO-blocked rats receiving combined acute AT1 and alpha 1-adrenoceptor blockade. These observations indicate that, in the sustained phase of chronic NO blockade, the hypertension is largely due to the combined activities of alpha 1-adrenoceptor and AT1 stimulation.
No takes yet. Share an insight, caveat, or question.
Qiu et al. (1994) studied Chronic nitric oxide blockade-induced hypertension. Combined AT1 and alpha 1-adrenoceptor blockade (losartan and prazosin) vs. Normal conscious rats and individual blockades was evaluated on Blood pressure and renal vascular resistance. Combined AT1 and alpha 1-adrenoceptor blockade profoundly lowered blood pressure in chronically NO-blocked rats, obliterating hypertension, though increased renal vascular resistance persisted.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: